Vistagen posts new corporate presentation; no specific financial updates

Vistagen Therapeutics, Inc.

Company released an updated corporate presentation on December 6, 2024.
Tagline: 'Pioneering neuroscience with nose-to-brain neurocircuitry'.
No new financial guidance, clinical results, or material transactions disclosed.

item 7.01 item 9.01

Vistagen Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001411685-24-000059

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.